These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2452305)

  • 21. Assessment in pig coronary artery of long-lasting and potent calcium antagonistic actions of the novel dihydropyridine derivative mepirodipine hydrochloride.
    Nakayama K; Kashiwabara T; Yamada S; Tanaka Y
    Arzneimittelforschung; 1989 Jan; 39(1):50-5. PubMed ID: 2470382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of vasoselective action of mebudipine, a new calcium channel blocker.
    Mirkhani H; Dirin M; Youssef-Zayeh I
    Vascul Pharmacol; 2004 Aug; 42(1):23-9. PubMed ID: 15664884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of atherogenesis in cholesterol-fed rabbits treated with nilvadipine, a new vasoselective calcium entry blocker.
    Koibuchi Y; Sakai S; Miura S; Ono T; Shibayama F; Ohtsuka M
    Atherosclerosis; 1989 Oct; 79(2-3):147-55. PubMed ID: 2597224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
    Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium channel blocking activity of calycosin, a major active component of Astragali Radix, on rat aorta.
    Wu XL; Wang YY; Cheng J; Zhao YY
    Acta Pharmacol Sin; 2006 Aug; 27(8):1007-12. PubMed ID: 16867251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory actions of a novel benzothiazepine derivative, TA3090, on the electrical and mechanical responses of the rabbit mesenteric artery.
    Nishiye E; Nakao K; Kitamura K; Kuriyama H
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1079-86. PubMed ID: 2778710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonist. Effect on cuff-induced intimal thickening of rabbit carotid artery.
    Nomoto A; Hirosumi J; Sekiguchi C; Mutoh S; Yamaguchi I; Aoki H
    Atherosclerosis; 1987 Apr; 64(2-3):255-61. PubMed ID: 3606723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Action of diltiazem on canine mesenteric artery smooth muscle.
    Fondacaro JD; Gallavan RH; Jacobson ED; DiSalvo J
    Artery; 1985; 12(6):352-62. PubMed ID: 4051755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery.
    Noguera I; Medina P; Segarra G; Martínez MC; Aldasoro M; Vila JM; Lluch S
    Br J Pharmacol; 1997 Oct; 122(3):431-8. PubMed ID: 9351498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and chronic captopril, but not prazosin or nifedipine, normalize alterations in adrenergic intracellular Ca2+ handling observed in the mesenteric arterial tree of spontaneously hypertensive rats.
    Miquel R; Gisbert R; Serna E; Perez-Vizcaino F; Anselmi E; Noguera MA; Ivorra MD; D'Ocon MP
    J Pharmacol Exp Ther; 2005 Apr; 313(1):359-67. PubMed ID: 15615866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular Ca2+ dependence and diltiazem inhibition of contraction in rabbit conduit arteries and mesenteric resistance vessels.
    Cauvin C; Saida K; van Breemen C
    Blood Vessels; 1984; 21(1):23-31. PubMed ID: 6689958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibited effects of amitriptyline on rabbit basilar and mesenteric artery rings].
    Lü AG; Ke J; Weng SA
    Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):518-20. PubMed ID: 2130616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the cardiovascular effect of FR34235, a new dihydropyridine, with other calcium antagonists.
    Ohtsuka M; Ono T; Hiroi J; Esumi K; Kikuchi H; Kumada S
    J Cardiovasc Pharmacol; 1983; 5(6):1074-82. PubMed ID: 6196557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist.
    Honerjäger P; Seibel K
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S15-21. PubMed ID: 1283184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro vasorelaxing activity of suloctidil.
    Calderon P; van Dorsser W; Geöcze von Szendroi K; De Mey JG; Roba J
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):101-13. PubMed ID: 3030204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nilvadipine inhibits acute rise of aqueous flare and intraocular pressure induced by prostaglandin E2 in pigmented rabbits.
    Zhang XY; Hiraki S; Hayasaka S
    Ophthalmic Res; 1998; 30(3):135-41. PubMed ID: 9618717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative cardiovascular actions of clentiazem, diltiazem, verapamil, nifedipine, and nimodipine in isolated rabbit tissues.
    Mecca TE; Love SD
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):678-82. PubMed ID: 1280727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of amlodipine, a new calcium antagonist on isolated blood vessels].
    Yamanaka K; Suzuki M; Munehasu S; Ishiko J
    Nihon Yakurigaku Zasshi; 1991 Mar; 97(3):167-78. PubMed ID: 1828241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.